SCNI
Scinai·NASDAQ
--
--(--)
--
--(--)
0.87 / 10
Underperform
Fundamental metrics indicate inadequate status for SCNI, with key factors such as Days sales outstanding (25.85 days, Group 2) and operating revenue growth (172.18% YoY, Group 3) yielding negative historical returns and low scores. Only Interest coverage ratio (27.58%, Group 1) provides a modestly positive signal. The composite fundamental score is 0.9/10, leading to an Underperform rating and a guarded outlook.
Analysis Checks(1/4)
Total operating revenue (YoY growth rate %)
Value172.18
Score0/3
Weight42.13%
1M Return-6.11%
Value172.18
Score0/3
Weight42.13%
1M Return-6.11%
Interest coverage ratio (EBIT / Interest expense) (%)
Value27.58
Score2/3
Weight9.09%
1M Return-1.11%
Value27.58
Score2/3
Weight9.09%
1M Return-1.11%
Days sales outstanding
Value25.85
Score1/3
Weight12.52%
1M Return-1.57%
Value25.85
Score1/3
Weight12.52%
1M Return-1.57%
Operating revenue (YoY growth rate %)
Value172.18
Score0/3
Weight36.26%
1M Return-5.06%
Value172.18
Score0/3
Weight36.26%
1M Return-5.06%
Total operating revenue (YoY growth rate %)
Value172.18
Score0/3
Weight42.13%
1M Return-6.11%
Value172.18
Score0/3
Weight42.13%
1M Return-6.11%
Days sales outstanding
Value25.85
Score1/3
Weight12.52%
1M Return-1.57%
Value25.85
Score1/3
Weight12.52%
1M Return-1.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value27.58
Score2/3
Weight9.09%
1M Return-1.11%
Value27.58
Score2/3
Weight9.09%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value172.18
Score0/3
Weight36.26%
1M Return-5.06%
Value172.18
Score0/3
Weight36.26%
1M Return-5.06%
Is SCNI undervalued or overvalued?
- SCNI scores 0.87/10 on fundamentals and holds a Premium valuation at present. Backed by its -46.36% ROE, 448.39% net margin, 0.56 P/E ratio, 0.37 P/B ratio, and 0.00% earnings growth, these metrics solidify its Underperform investment rating.
